Tabla de Contenidos: “…-- The Three Pillars of Cybersecurity -- Two Approaches to Security -- Physical Security: Locking Your Doors -- Securing User Accounts -- Obfuscating your usernames -- Using passwords wisely -- Generating passwords For Dummies -- Secure the Administrator account -- Managing User Security -- User accounts -- Built-in accounts -- User rights -- Permissions (who gets what) -- Group therapy -- User profiles -- Logon scripts -- Securing the Human Firewall -- Chapter 20 Hardening Your Network -- Firewalls -- The Many Types of Firewalls -- Packet filtering -- Stateful packet inspection (SPI) -- Circuit-level gateway -- Application gateway -- Next-generation firewall -- Virus Protection -- What is a virus? -- Antivirus programs -- Safe computing…”

Tabla de Contenidos: “…Conclusion -- References -- 10 - Understanding virus-bacteria-human tripartite interactions: strategies and challenges -- 1. …”

Tabla de Contenidos: “…Review of the Fialuridine (FIAU) Clinical Trials -- Copyright -- Preface -- Contents -- Executive Summary -- INTRODUCTION -- CLINICAL TRIALS -- HEPATITIS B AND OTHER VIRAL DISEASES -- EARLY CLINICAL TRIALS OF FIAC AT MEMORIAL SLOAN-KETTERING CANCER CENTER -- OCLASSEN CLINICAL TRIAL R89-001-01 -- OCLASSEN CLINICAL TRIAL R90-001-01 -- OCLASSEN CLINICAL TRIAL R-91-010 -- ELI LILLY CLINICAL TRIAL H3X-MC-PPPA -- ELI LILLY TRIAL H3X-LC-PPPG -- ELI LILLY TRIAL H3X-MC-PPPC (NIH PROTOCOL #93-DK-0031) -- PATIENT INTERVIEWS -- OVERALL ASSESSMENT OF THE TRIALS -- REVIEW OF THE FDA TASK FORCE REPORT -- REVIEW OF THE NIH REPORT -- FDA-PROPOSED CHANGES TO THE CODE OF FEDERAL REGULATIONS -- ANCILLARY ISSUES -- CONCLUSIONS -- RECOMMENDATIONS -- Generic Issues -- Trial Design -- Adverse Event Reporting -- Compliance Audits -- Further Research Into FIAU Toxicity -- 1 Introduction -- GENESIS OF THIS STUDY -- CHARGE TO THE COMMITTEE -- METHODS AND PROCEDURE -- PLAN OF THE REPORT -- 2 Clinical Trials -- IMPORTANCE OF CLINICAL TRIALS -- THE RISK-BENEFIT NATURE OF TRIALS -- THE DRUG DEVELOPMENT PROCESS -- SAFETY REPORTS -- ETHICAL CONSIDERATIONS -- Procedural Requirements -- Substantive Norms -- A Favorable Balance of Harms and Benefits -- Equitable Selection of Subjects -- Compensation for Research-Related Injury -- Informed Consent -- SUMMARY -- 3 Hepatitis B and Other Viral Diseases -- NATURE OF CHRONIC VIRAL DISEASES -- NATURAL HISTORY OF CHRONIC HBV INFECTION -- NEED FOR ORALLY ACTIVE AGENTS -- THE FLARE PHENOMENON -- TOXIC EFFECTS OF OTHER NUCLEOSIDE ANALOGS -- SUMMARY -- 4 Clinical Trials of FIAC at Memorial Sloan-Kettering Cancer Center -- PHASE I EVALUATION OF FIAC IN IMMUNOSUPPRESSED PATIENTS WITH HERPESVIRUS INFECTION -- Comment -- PHASE I STUDY OF AIDS PATIENTS WITH PRESUMPTIVE OR PROVEN HERPESGROUP VIRUS INFECTION -- Comment…”

Tabla de Contenidos: “…Virosis; 8.1.1. Tipo de virus Dentro de la legislación que; 8.1.2. Variedad; 8.1.3. …”

Tabla de Contenidos: “…¿Qué es un superconductor?; 59. ¿Qué es un virus?; 60. ¿Por qué echamos sal a la carretera?; 61. …”

Tabla de Contenidos: “…DiPiro -- Chapter 35: Antimicrobial Regimen Selection -- Chapter 36: Central Nervous System Infections -- Chapter 37: Endocarditis -- Chapter 38: Fungal Infections, Invasive -- Chapter 39: Fungal Infections, Superficial -- Chapter 40: Gastrointestinal Infections -- Chapter 41: Human Immunodeficiency Virus Infection -- Chapter 42: Influenza -- Chapter 43: Intra-Abdominal Infections -- Chapter 44: Respiratory Tract Infections, Lower -- Chapter 45: Respiratory Tract Infections, Upper -- Chapter 46: Sepsis and Septic Shock -- Chapter 47: Sexually Transmitted Diseases -- Chapter 48: Skin and Soft-Tissue Infections -- Chapter 49: Surgical Prophylaxis -- Chapter 50: Tuberculosis -- Chapter 51: Urinary Tract Infections -- Chapter 52: Vaccines, Toxoids, and Other Immunobiologics -- SECTION 9: NEUROLOGIC DISORDERS Edited by Vicki L. …”

Tabla de Contenidos: “…-- War and its actors -- Advanced persistent threats -- The Colonial Pipeline attack -- The Shamoon virus -- Stuxnet -- Operation Desert Storm -- Impact of cyberwarfare -- Summary -- Chapter 11: An Introduction to Regulatory Risks -- Regulatory risks - an introduction -- Digitization and the expansion of the regulatory risk landscape across sectors -- Speed -- Scale -- Interdependence -- A framework to understand modern regulatory risks for all businesses -- Summary -- Chapter 12: The Evolution of Risk and Compliance Management -- What is risk?…”

Tabla de Contenidos: “…Machine generated contents note: Introduction PART I: BACKGROUND 2 Vertebrate Immunity 2.1 Nonspecific Immunity 2.2 Specific Immunity: Antigens and Epitopes 2.3 B Cells and Antibodies 2.4 T Cells and MHC 2.5 Summary 3 Benefits of Antigenic Variation 3.1 Extend Length of Infection 3.2 Infect Hosts with Prior Exposure 3.3 Infect Hosts with Genetically Variable Resistance 3.4 Vary Attachment Characters 3.5 Antigenic Interference 3.6 Problems for Future Research PART II: MOLECULAR PROCESSES 4 Specificity and Cross-Reactivity 4.1 Antigens and Antibody Epitopes 4.2 Antibody Paratopes 4.3 Antibody Affinity Maturation 4.4 Natural Antibodies-Low-Affinity Binding to Diverse Antigens 4.5 Affinity versus Specificity 4.6 Cross-Reaction of Polyclonal Antibodies to Divergent Antigens 4.7 T Cell Epitopes 4.8 Every Host Differs 4.9 Problems for Future Research 5 Generative Mechanisms 5.1 Mutation and Hypermutation 5.2 Stochastic Switching between Archival Copies 5.3 New Variants by Intragenomic Recombination 5.4 Mixing between Genomes 5.5 Problems for Future Research PART III: INDIVIDUAL INTERACTIONS 6 Immunodominance within Hosts 6.1 Antibody Immunodominance 6.2 CTL Immunodominance 6.3 Sequence of Exposure to Antigens: Original Antigenic Sin 6.4 Problems for Future Research 7 Parasite Escape within Hosts 7.1 Natural Selection of Antigenic Variants 7.2 Pathogen Manipulation of Host Immune Dynamics 7.3 Sequence of Variants in Active Switching from Archives 7.4 Ecological Coexistence of Variants within a Host 7.5 Problems for Future Research PART IV: POPULATION CONSEQUENCES 8 Genetic Variability of Hosts 8.1 Polymorphisms in Specificity 8.2 Polymorphisms in Immune Regulation 8.3 Problems for Future Research 9 Immunological Variability of Hosts 9.1 Immunological Memory 9.2 Kinds of Parasites 9.3 Immunodominance of Memory 9.4 Cross-Reactivity and Interference 9.5 Distribution of Immune Profiles among Hosts 9.6 Problems for Future Research 10 Genetic Structure of Parasite Populations 10.1 Kinds of Genetic Structure 10.2 Pattern and Process 10.3 Genome-wide Linkage Disequilibrium 10.4 Antigenic Linkage Disequilibrium 10.5 Population Structure: Hosts as Islands 10.6 Problems for Future Research PART V: STUDYING EVOLUTION 11 Classifications by Antigenicity and Phylogeny 11.1 Immunological Measures of Antigenicity 11.2 Phylogeny 11.3 Hypothetical Relations between Immunology and Phylogeny 11.4 Immunology Matches Phylogeny over Long Genetic Distances 11.5 Immunology-Phylogeny Mismatch with Radiations into New Hosts 11.6 Short-Term Phylogenetic Diversification Driven by Immunological Selection 11.7 Discordant Patterns of Phylogeny and Antigenicity Created by Within-Host Immune Pressure 11.8 Problems for Future Research 12 Experimental Evolution: Foot-and-Mouth Disease Virus 12.1 Overview of Antigenicity and Structure 12.2 Antibody Escape Mutants 12.3 Cell Binding and Tropism 12.4 Fitness Consequences of Substitutions 12.5 Problems for Future Research 13 Experimental Evolution: Influenza 13.1 Overview of Antigenicity and Structure 13.2 Antibody Escape Mutants 13.3 Cell Binding and Tropism 13.4 Fitness Consequences of Substitutions 13.5 Experimental Evolution of Other Pathogens 13.6 Problems for Future Research 14 Experimental Evolution: CTL Escape 14.1 Cleavage and Transport of Peptides 14.2 MHC Binding. 14.3 TCR Binding 14.4 Functional Consequences of Escape 14.5 Kinetics of Escape 14.6 Problems for Future Research 15 Measuring Selection with Population Samples 15.1 Kinds of Natural Selection 15.2 Positive Selection to Avoid Host Recognition 15.3 Phylogenetic Analysis of Nucleotide Substitutions 15.4 Predicting Evolution 15.5 Problems for Future Research 16 Recap of Some Interesting Problems 16.1 Population-Level Explanation for Low Molecular Variability 16.2 Molecular-Level Explanation for Population Dynamics 16.3 Binding Kinetics and the Dynamics of Immunodominance 16.4 Diversity and Regulation of Archival Repertoires 16.5 Final Note…”

Tabla de Contenidos: “…Gronau</i>10 Unexpectedly withdrawn and still engaged: reflections on the experiences of the Roman writer and politician Marcus Tullius Cicero<br><i>Gesine Manuwald</i>11 The Gallic Sack of Rome: an exemplum for our times<br><i>Elizabeth McKnight</i>12 On Spinalonga<br><i>Panayiota Christodoulidou</i></p><p><b>Part III: Performance, identity and the screen</b>13 The thing itself<br><i>Alexander Samson</i>14 Towards a new history: The corona-seminar and the drag king virus<br><i>Helena Fallstrom</i>15 'In spite of the tennis': Beckett's sporting apocalypse'<br><i>Sam Caleb</i>16 Screening dislocated despair: projecting the neoliberal left-behinds in <i>100 Flowers Hidden Deep</i><br><i>Nashuyuan Serenity Wang</i>17 A digital film for digital times: some lockdown thoughts on <i>Gravity</i><br><i>Stephen M. …”

Tabla de Contenidos: “…Agentes antivirales -- Antivirales contra los virus herpes -- Agentes antirretrovirales -- Otros agentes antivirales -- Lecturas recomendadas -- Capítulo 8. …”

Tabla de Contenidos: “…Proyectos terminados -- Fomento de estrategias de promoción de lectura y participación social para desarrollar con personal bibliotecario y agentes culturales en la ciudad de Mitú, Vaupés -- Cambios en la película lagrimal durante treinta días de uso de lentes de contacto blandos -- Programa de Fortalecimiento en Competencias Informacionales para jóvenes de 15 a 18 años, en la Biblioteca Alberto Gutiérrez, en la localidad de Los Mártires -- Repetibilidad y reproducibilidad de las medidas del espesor y curvatura corneal obtenidas mediante el Pentacam HR (Oculus) -- Evaluación de dos métodos de suministro de calostro en neonatos bovinos, hacienda La Esperanza, Sopó, Cundinamarca -- Relación de los indicadores reproductivos con la presencia de Leptospira spp. en dos granjas porcinas de Cundinamarca -- Estudio exploratorio de la presencia de los virus de las enfermedades de Newcastle y Gumboro en aves silvestres de explotaciones avícolas en la zona centro-oriental de Colombia -- Comentarios finales…”

Tabla de Contenidos: “…Importance of food quality analysis in relation to food safety and human health and COVID-19 in particular -- 1.1 Introduction -- 1.2 Importance of food quality analysis -- 1.3 Compositional analysis of foods -- 1.3.1 Moisture analysis -- 1.3.2 Fat analysis -- 1.3.3 Protein analysis -- 1.3.4 Carbohydrate analysis -- 1.3.5 Vitamin analysis -- 1.3.6 Mineral analysis -- 1.4 Chemical analysis of foods -- 1.4.1 pH analysis -- 1.4.2 Enzyme analysis -- 1.4.3 Food contaminants analysis -- 1.4.3.1 Pesticide analysis -- 1.4.3.2 Mycotoxin analysis -- 1.5 Importance of food analysis in relation to COVID-19 -- 1.5.1 Food safety management in COVID-19 era -- 1.5.2 SARS-CoV-2 virus analysis -- 1.6 Future prospects -- 1.7 Conclusions -- References -- 2. …”

Tabla de Contenidos: “…-- AIII.2 ¿MÁS VÍCTIMAS DE LA CRISIS ECONÓMICA QUE DEL VIRUS? -- AIII.3 ¿EL LOCKDOWN ES BUENO PARA LA RECUPERACIÓN ECONÓMICA? …”

Tabla de Contenidos: “…4.3.2 Einstellung der Bevölkerung zur Blockchain-basierten E-ID -- 4.3.2.1 Vertrauen in den Staat -- 4.3.2.2 Wahrnehmung und Einordnung der digitalen ID -- 4.3.2.3 Anwendungsbereiche der digitalen ID im öffentlichen Sektor und in der digitalen Demokratie -- 4.3.2.4 Vorkenntnisse und Einstellung gegenüber der Blockchain-Technologie -- 4.3.2.5 Einstellung gegenüber der Self-Sovereign Identity -- 4.3.2.6 Einstellung gegenüber einer digitalen ID auf Basis von Blockchain-Technologie -- 4.3.2.7 Abstimmungsabsicht bezüglich einer staatlichen und Blockchain-basierten ID-Lösung -- 4.3.2.8 Gründe für und gegen eine staatliche und Blockchain-basierte ID-Lösung -- 4.3.2.9 Einfluss der Kompetenz auf den Zustimmungsgrad -- 4.4 Schlussfolgerungen -- Literatur -- 5: Hackathon als Open Innovation in der öffentlichen Verwaltung -- 5.1 Einleitung -- 5.1.1 Zielsetzung -- 5.2 Theoretische Grundlagen -- 5.2.1 Open Government -- 5.2.2 Open Innovation (OI) -- 5.2.3 Innovation in der öffentlichen Verwaltung -- 5.3 Hackathon - von der Idee zur praktischen Umsetzung -- 5.3.1 Begriffsdefinition -- 5.3.2 Merkmale und Design -- 5.3.3 Civic Hackathons -- 5.3.3.1 Data Hackdays BE 2021 -- 5.3.3.2 #WirVsVirus und Update Deutschland -- 5.3.3.3 Versus Virus -- 5.3.4 Nutzen -- 5.3.5 Verbesserungen -- 5.3.6 Ergebnisse weiterführen -- 5.3.7 Kritik und Herausforderungen -- 5.4 Ergebnisse -- 5.4.1 Forschungsfrage -- 5.4.2 Innovationsfähigkeit -- 5.4.3 Vorbereitung und Unterstützung -- 5.4.4 Daten und Tools -- 5.4.5 Hackathon Design -- 5.4.6 Umsetzung der Ergebnisse -- 5.5 Fazit und Ausblick -- Literatur -- 6: Digitale Transformation = mehr Nachhaltigkeit in der Logistik? …”

Tabla de Contenidos: “…Población joven en el mercado laboral colombiano -- Situación laboral de la población joven en Cali -- Generalidades sobre programas y políticas de apoyo a la población joven -- Riesgos y preocupaciones de la población joven -- Atención psicosocial y de salud -- Características sociodemográficas y de vivienda -- Barreras para acceder al mercado laboral -- Bajos niveles educativos -- Condición étnico-racial -- Género -- Vínculos previos con pandillas -- Oferta laboral permanente en actividades ilegales -- Capital social limitado -- Fronteras urbanas, segregación, racismo y estigmatización -- La situación de las personas jóvenes vulnerables -- Control territorial, pandillas y crimen organizado -- La fuerza de los vínculos y el acceso a información sobre empleo -- Redes y estatus laboral -- Educación, capital humano y empleabilidad -- Trayectorias laborales en desigualdad concentrada -- La carga violenta del pasado -- Economía, riesgo multidimensional y violencia -- La estructura de las redes -- los efectos de la pandemia sobre los más vulnerables -- Medidas para enfrentar la pandemia -- Los efectos más visibles en las poblaciones vulnerables -- Medidas para detener el virus y formas de contagio -- Evolución de la pandemia entre marzo y agosto del 2020 -- aprendizajes y recomendaciones -- para la inclusión laboral y social de la población joven vulnerable -- Síntesis sobre programas de empleabilidad para la población joven -- Lecciones aprendidas en el proceso de investigación-intervención con la población joven -- Lecciones aprendidas y recomendaciones -- Agradecimientos -- Referencias bibliográficas -- Situación laboral de la población joven…”

Tabla de Contenidos: “…Ka, Aurélie Daumas, Julien Textoris and Jean-Louis Mege -- The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseases / Kristina S. Burrack and Thomas E. …”

Tabla de Contenidos: “…Case 001-Surgical Care -- Case 002-Hypertension Case # 1 -- Case 003-Hypertension Case # 2 -- Case 004-Hypertension Case # 3 -- Case 005-Hypertension Case # 4 -- Case 006-Hypertension Case # 5 -- Case 007-Dyslipidemia Case # 1 -- Case 008-Dyslipidemia Case # 2 -- Case 009-Stable Ischemic Heart Disease -- Case 010-Acute Coronary Syndromes -- Case 011-Cardiovascular Respiratory Decompensation -- Case 012-Chronic Heart Failure Case # 1 -- Case 013-Chronic Heart Failure Case # 2 -- Case 014-Venous Thromboembolism-Pulmonary Embolism Case # 1 -- Case 015-Venous Thromboembolism-Pulmonary Embolism Case # 2 -- Case 016-Stroke -- Case 017-Arrhythmias -- Case 018-Cardiac Arrest, Resuscitation -- Case 019-Acne and Pediatric Dermatology Disorders -- Case 020-Psoriasis -- Case 021-Atopic Dermatitis -- Case 022-Miscellaneous Dermatology -- Case 023-Peptic Ulcer Disease, GERD Case # 1 -- Case 024-Peptic Ulcer Disease, GERD Case # 2 -- Case 025-Irritable Bowel Syndrome -- Case 026-Diarrhea -- Case 027-Constipation -- Case 028-Crohn Disease -- Case 029-Anemia -- Case 030-CNS Infections -- Case 031-Lower Respiratory Tract Infection -- Case 032-Upper Respiratory Tract Infection -- Case 033-Skin and Soft-Tissue Infections; Fungal (Multiple Patient Case) -- Case 034-Infective Endocarditis -- Case 035-Gastrointestinal Infections -- Case 036-Intra-Abdominal Infections -- Case 037-Urinary Tract Infection -- Case 038-Skin and Soft Tissue Infection (Bacterial), Bone and Joint Infections -- Case 039-Miscellaneous Bacterial Infections -- Case 040-Sexually Transmitted Infections -- Case 041-Sepsis and Septic Shock -- Case 042-Fungal Infections Case # 1 -- Case 043-Fungal Infections Case # 2 -- Case 044-Viral Infections -- Case 045-Parasitic Infections -- Case 046-Infectious Endocarditis -- Case 047-Viral Hepatitis, Hepatitis Vaccination -- Case 048-Influenza and Influenza Vaccination (Multiple Patient Case) -- Case 049-Foot and Nail Fungal Infection -- Case 050-Vaccines Case # 1 -- Case 051-Vaccines Case # 2 -- Case 052-Travel Health (Multiple Patient Case) -- Case 053-Human Immunodeficiency Virus Infection -- Case 054-Systemic Lupus Erythematosus -- Case 055-Solid Organ Transplantation -- Case 056-Erectile Dysfunction -- Case 057-Benign Prostatic Hyperplasia -- Case 058-Attention Deficit Hyperactivity Disorder -- Case 059-Substance Use Disorders (Opioids) -- Case 060-Substance-Related Disorders (Alcohol, Nicotine) -- Case 061-Schizophrenia -- Case 062-Depression Case # 1 -- Case 063-Depression Case # 2 -- Case 064-Panic Disorder -- Case 065-Bipolar Disorder -- Case 066-Anxiety Disorders Case # 1 -- Case 067-Anxiety Disorders Case # 2 -- Case 068-Sleep-Wake Disorders -- Case 069-Diabetes Mellitus (Type 2) Case # 1 -- Case 070-Diabetes Mellitus (Type 2) Case # 2 -- Case 071-Diabetes Mellitus (Type 2) Case # 3 -- Case 072-Thyroid Disorders -- Case 073-Obesity -- Case 074-Migraine Headache -- Case 075-Critical Care Pain, Agitation, Delirium -- Case 076-Alzheimer Disease -- Case 077-Multiple Sclerosis -- Case 078-Epilepsy Case # 1 -- Case 079-Epilepsy Case # 2 -- Case 080-Parkinson Disease -- Case 081-Pain Management Case # 1 -- Case 082-Pain Management Case # 2 -- Case 083-Pain Management Case # 3 -- Case 084-Brain Cancer -- Case 085-Breast Cancer -- Case 086-Lung Cancer -- Case 087-Colorectal Cancer -- Case 088-Prostate Cancer -- Case 089-Hodgkin Lymphoma -- Case 090-Lymphoma -- Case 091-Acute Myeloid Leukemia -- Case 092-Chronic Lymphocytic Leukemia -- Case 093-Multiple Myeloma -- Case 094-Myelodysplastic Syndrome -- Case 095-Renal Cell Cancer -- Case 096-Melanoma -- Case 097-Ovarian Cancer -- Case 098-Chemotherapy-Induced Emesis -- Case 099-Cancer Pain -- Case 100-Stem Cell Transplant -- Case 101-Idiopathic Thrombocytopenic Purpura, Thrombotic Thrombocytopenic Purpura -- Case 102-Glaucoma -- Case 103-Bacterial Conjunctivitis -- Case 104-Allergic Conjunctivitis -- Case 105-Asthma Case # 1 -- Case 106-Asthma Case # 2 -- Case 107-Allergic Rhinitis Case # 1 -- Case 108-Allergic Rhinitis Case # 2 -- Case 109-Chronic Obstructive Pulmonary Disease -- Case 110-Osteoarthritis -- Case 111-Rheumatoid Arthritis -- Case 112-Osteoporosis -- Case 113-Gout -- Case 114-Urinary Disorders - Male -- Case 115-Urinary Disorders - Female -- Case 116-Menopause Care -- Case 117-Menstruation-Related Disorders -- Case 118-Contraception -- Case 119-Obstetric Care -- Case 120-Family Medicine Case # 1 (Multiple Patient Case) -- Case 121-Family Medicine Case # 2 (Multiple Patient Case) -- Case 122-Family Medicine Case # 3 (Multiple Patient Case) -- Case 123-Family Medicine Case # 4 (Multiple Patient Case) -- Case 124-Family Medicine Case # 5 (Multiple Patient Case) -- Case 125-Family Medicine Case # 6 (Multiple Patient Case)…”

Tabla de Contenidos: “…-- 2.1 Introduction -- 2.2 Method -- 2.2.1 Subjects -- 2.2.2 Decision scenarios -- 2.2.3 Experimental procedure -- 2.3 Results -- 2.3.1 Data classification -- 2.3.2 Hypothesis testing -- 2.4 Discussion -- Acknowledgements -- References -- Appendices -- Appendix A: Experimental scenarios -- Appendix B: Virus infection scenario (warm-up task) from Bär and Huber (2008) -- Appendix C: Choice list for the Holt and Laury (2002) task -- Appendix D: Question for general risk taking assessment -- Appendix E: Significance of Mann-Whitney U statistics (all tests are one-sided) -- Appendix F: Statistics by gender (means are weighted by the corresponding group sizes) -- Chapter 3: Overweighting versus underweighting of small probabilities -- 3.1 Underweighting and Overweighting of Small Probabilities -- 3.2 When do People Tend to Overweight Small Probabilities? …”

“…Over 100 recipes for penetration testing using Metasploit and virtual machines About This Book Special focus on the latest operating systems, exploits, and penetration testing techniques Learn new anti-virus evasion techniques and use Metasploit to evade countermeasures Automate post exploitation with AutoRunScript Exploit Android devices, record audio and video, send and read SMS, read call logs, and much more Build and analyze Metasploit modules in Ruby Integrate Metasploit with other penetration testing tools Who This Book Is For If you are a Security professional or pentester and want to get into vulnerability exploitation and make the most of the Metasploit framework, then this book is for you. …”

“…Master the art of detecting and averting advanced network security attacks and techniques About This Book Deep dive into the advanced network security attacks and techniques by leveraging tools such as Kali Linux 2, MetaSploit, Nmap, and Wireshark Become an expert in cracking WiFi passwords, penetrating anti-virus networks, sniffing the network, and USB hacks This step-by-step guide shows you how to confidently and quickly detect vulnerabilities for your network before the hacker does Who This Book Is For This book is for network security professionals, cyber security professionals, and Pentesters who are well versed with fundamentals of network security and now want to master it. …”